Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

Qian Li,Rahul Ganguly,Michael L. Ganz,Cory Gamble,Tam Dang-Tan

Real-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years

2018

Qian Li
Rahul Ganguly
Michael L. Ganz
Cory Gamble
Tam Dang-Tan

Introduction This study compared the clinical and economic outcomes of long-term use of liraglutide versus sitagliptin for the treatment of type 2 diabetes (T2DM) in real-world practice in the USA.

Keywords:

Diabetes mellitus
Liraglutide
Type 2 diabetes
Endocrinology
Physical therapy
Internal medicine
Sitagliptin
Medicine
Glycated hemoglobin
Odds ratio
Pharmacy
Glycemic

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations